<DOC>
	<DOCNO>NCT02305394</DOCNO>
	<brief_summary>Electroconvulsive therapy ( ECT ) effective treatment depression compare current antidepressant agentsï¼Œbut important side effect cognitive dysfunction . The purpose study determine whether subanesthetic dose ketamine combine propofol superior propofol anesthesia alone improve cognitive function depressive patient undergo ECT .</brief_summary>
	<brief_title>Effect Subanesthetic Dose Ketamine Combined With Propofol Cognitive Function Depressive Patients Undergoing Electroconvulsive Therapy</brief_title>
	<detailed_description>Depression one debilitate widespread illness affect 20 % individual lifetime . However , current antidepressant agent take week work , fail help least 40 % depressed patient . Electroconvulsive therapy ( ECT ) remarkably effective treatment depression , use limit cognitive dysfunction . As result , become clinical problem need settle urgently . Previous clinical study show subanesthetic dose ketamine could play role antidepressant effect safety minimal positive psychotic symptoms.The investigator also find subanesthetic dose ketamine combine anesthetic could improve cognitive function depressive rat receive electroconvulsive shock ( model analogy ECT ) . Few clinical research concerned effect subanesthetic dose ketamine combine propofol anesthesia cognitive function patient ECT , therefore investigator conduct randomize control double-blind trial . In study , cognitive function rat Mini-Mental State examination score .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>1. diagnosed moderate severe depression accord Diagnostic Statistical Manual Mental Disorders 2. age 18 65 year old 1. cerebrovascular malformation , arterial aneurysm , hypertension , glaucoma ; 2. classification American Society Anesthesiologists physical status score IV V ; 3. complication respiratory disease , cardiovascular disease , intracranial hypertension , cerebral vascular disorder ; 4. presence foreign body pacemaker , intracranial electrode , clip ; 5. history seizure ; 6. history drug abuse ; 7. concomitant presence mental disorder ; 8. pregnancy ; 9. history serious adverse effect related anesthetic ; 10. refusal consent study , refusal undergo one single ECT first week therapy . 11. hyperthyreosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>ketamine</keyword>
	<keyword>Electroconvulsive Therapy</keyword>
	<keyword>Cognitive Function</keyword>
</DOC>